CRPC w/ Bone Metastases
Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers.
January 19, 2021
Randomized phase II trial of sipuleucel-T with or without radium-223 in men with bone-metastatic castration-resistant prostate cancer.
January 18, 2021
Evaluation of safety and dosimetry of 177Lu DOTA-ZOL for therapy of bone metastases.
January 11, 2021
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
December 29, 2020
Bone Infarction Mimicking a Bone Metastasis on 18F-Prostate-Specific Membrane Antigen PET/CT.
December 22, 2020
Management of cancer pain with analgetic adjuvant and weak opioid in prostate cancer bone metastases: A case series.
December 14, 2020
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
December 7, 2020
The Role of Theranostics in Prostate Cancer.
December 2, 2020
Radium-223 therapy for metastatic castration-resistant prostate cancer: survival benefit when used earlier in the treatment pathway.
December 2, 2020
Radiopharmaceuticals for Bone Metastases.
December 1, 2020
Review of Palliative Radium 223 (223Ra) in metastatic castration resistant prostate cancer (mCRPC): Experience at West Virginia University (WVU) Cancer Center.
November 24, 2020
Bone-targeted calcium phosphate-polymer hybrid nanoparticle co-deliver zoledronate and docetaxel to treat bone metastasis of prostate cancer.
November 18, 2020
Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.
November 17, 2020
Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CT.
November 16, 2020
Pharmacologic Management of Metastatic Bone Disease.
November 13, 2020